Analyst
Canaccord Genuity
Equibles does not estimate personal net worth.
John Young is recorded as Analyst at Canaccord Genuity. John Young has spoken on 9 earnings calls across 3 companies, most recently for Angiodynamics Inc on October 8, 2026. Those appearances were for Angiodynamics Inc (ANGO), CVRx, Inc. (CVRX) and iRhythm Holdings, Inc. (IRTC). The companies whose calls John Young spoke on are classified in the Healthcare sector.
“And, Jim, congratulations again on the past 10 years and best wishes for your retirement. I also wanted to talk about the mechanical farm-dactomy business with you guys.”
“Palmetto, the LCD going live as of January 5th. What change in neurologic adoption or account additions have you seen so far? And, you know, what's the timeline for any expected benefit from this? and then maybe you could walk us through what the regional coverage to broader national coverage pathway looks like.”
“I just want to start off on the reiteration of the revenue guidance. You guys had a solid Q1B. I'm wondering, the reiteration itself, is that just Q1 conservatism, or are you seeing anything maybe beyond the reimbursive dynamics that you already highlighted as we sit here Yeah, happy to take that one, John.”
“The sequential growth there was really impressive. Any additional color on the drivers? I know it was a bit subsequent to the quarter, but are you seeing any benefit today from the PE guidelines that were released in February?”
“Was that the 75 number that you provided and prepared remarks and any commentary on volume improvements that you're seeing from Aura? And is that embedded in the core company guidance expectations for 2026, or is that another source of potential upside?”
Canaccord Genuity
Analyst
Transcript header (unverified)
ANGO
Medical Instruments & Supplies · Healthcare
CVRX
Medical Devices · Healthcare
